Biocompatibility should not be viewed as a final regulatory hurdle-it should be a strategic consideration integrated throughout product development. By incorporating biocompatibility planning from the onset, manufacturers can identify potential risks earlier, make informed material and design decisions, and reduce the likelihood of costly delays during the safety testing process.
During this webinar, we will discuss: